Loading your page…
Marketing-authorisation holder
9 medicines in 3 countries, as authorisation holder.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine in the registers under its name, current ones first.
9 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Rasilez 150 mg, filmomhulde tabletFilmomhulde tablet | Aliskiren | Netherlands | Authorised | 2007 |
| Rasilez 300 mg, filmomhulde tabletFilmomhulde tablet | Aliskiren | Netherlands | Authorised | 2007 |
| RASILEZ150 mg · Tablet | Aliskiren | Canada | Cancelled | 2007 |
| RASILEZ300 mg · Tablet | Aliskiren | Canada | Cancelled | 2007 |
| RASILEZ HCT300 mg + 25 mg · Tablet | Aliskiren, Hydrochlorothiazide | Canada | Cancelled | 2009 |
| RASILEZ HCT300 mg + 12.5 mg · Tablet | Aliskiren, Hydrochlorothiazide | Canada | Cancelled | 2009 |
| RASILEZ HCT150 mg + 25 mg · Tablet | Aliskiren, Hydrochlorothiazide | Canada | Cancelled | 2009 |
| Rasilez HCT | Aliskiren, Hydrochlorothiazide | EU (EMA) | Withdrawn | 2009 |
| RASILEZ HCT150 mg + 12.5 mg · Tablet | Aliskiren, Hydrochlorothiazide | Canada | Cancelled | 2009 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 6 | 0 | 6 | CompaniesAll medicines |
| Netherlands | 2 | 2 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Italy
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Report an error or request removalCorrections from the company itself are welcome.
